155 related articles for article (PubMed ID: 24061639)
1. Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis.
Liu J; Zhou Z; Lai T; Yin J
Tumour Biol; 2014 Feb; 35(2):1083-7. PubMed ID: 24061639
[TBL] [Abstract][Full Text] [Related]
2. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
Wang Z; Zhang W
Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
[TBL] [Abstract][Full Text] [Related]
3. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
[TBL] [Abstract][Full Text] [Related]
4. XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
Qiu M; Xu L; Yang X; Ding X; Hu J; Jiang F; Xu L; Yin R
PLoS One; 2013; 8(10):e77005. PubMed ID: 24116196
[TBL] [Abstract][Full Text] [Related]
5. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.
Xu YH; Gu LP; Sun YJ; Cheng BJ; Lu S
Tumour Biol; 2013 Apr; 34(2):865-74. PubMed ID: 23300009
[TBL] [Abstract][Full Text] [Related]
6. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.
Yan Y; Liang H; Li T; Guo S; Li M; Qin X; Li S
Leuk Lymphoma; 2014 Sep; 55(9):2130-4. PubMed ID: 24304418
[TBL] [Abstract][Full Text] [Related]
7. Association of XRCC3 Thr241Met polymorphisms and gliomas risk: evidence from a meta-analysis.
Liang HJ; Yan YL; Liu ZM; Chen X; Peng QL; Wang J; Mo CJ; Sui JZ; Wu JR; Zhai LM; Yang S; Li TJ; Li RL; Li S; Qin X
Asian Pac J Cancer Prev; 2013; 14(7):4243-7. PubMed ID: 23991984
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.
Wang Z; Chen X; Liu B; Li S; Liu M; Xue H
Tumour Biol; 2014 Feb; 35(2):1589-98. PubMed ID: 24197974
[TBL] [Abstract][Full Text] [Related]
9. XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.
Shen XY; Lu FZ; Wu Y; Zhao LT; Lin ZF
PLoS One; 2013; 8(8):e69553. PubMed ID: 23940523
[TBL] [Abstract][Full Text] [Related]
10. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
[TBL] [Abstract][Full Text] [Related]
11. Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population.
Guo J; Lv HC; Shi RH; Liu WL
Genet Mol Res; 2015 Dec; 14(4):16484-90. PubMed ID: 26662447
[TBL] [Abstract][Full Text] [Related]
12. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
Chai F; Liang Y; Chen L; Zhang F; Jiang J
Med Sci Monit; 2015 Oct; 21():3231-40. PubMed ID: 26498491
[TBL] [Abstract][Full Text] [Related]
13. Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.
Tian X; Tian Y; Ma P; Sui C; Meng F; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
Tumour Biol; 2013 Oct; 34(5):2589-97. PubMed ID: 23749486
[TBL] [Abstract][Full Text] [Related]
14. Association of X-ray cross-complementing group 3 Thr241Met gene polymorphism with osteosarcoma risk and its development and prognosis.
Wang Y; Wang G; Dong Z
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1178-S1182. PubMed ID: 30539867
[TBL] [Abstract][Full Text] [Related]
15. Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.
Zhang W; Yan B; Jiang L
Tumour Biol; 2013 Dec; 34(6):3989-93. PubMed ID: 23990458
[TBL] [Abstract][Full Text] [Related]
16. Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis.
Yu X; Wang Q; He G; Yu H
Cancer Genet; 2021 Jun; 254-255():11-17. PubMed ID: 33515810
[TBL] [Abstract][Full Text] [Related]
17. XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Wu XT
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):226-34. PubMed ID: 24315014
[TBL] [Abstract][Full Text] [Related]
18. Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population.
Yang L; An Y; Wang G; Lu T; Yang S
Int J Clin Exp Pathol; 2015; 8(9):11670-4. PubMed ID: 26617908
[TBL] [Abstract][Full Text] [Related]
19. XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis.
Yan Y; Liang H; Li R; Xie L; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):2711-5. PubMed ID: 24254304
[TBL] [Abstract][Full Text] [Related]
20. XRCC3 Thr241Met polymorphism and risk of acute myeloid leukemia in a Romanian population.
Bănescu C; Tilinca M; Benedek EL; Demian S; Macarie I; Duicu C; Dobreanu M
Gene; 2013 Sep; 526(2):478-83. PubMed ID: 23747401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]